Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
Go back to Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update| (NASDAQ: KYNB) | Delayed: 7.13 +0.37 (5.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.76 | 52 Week High | $ | |||
| Open | $6.80 | 52 Week Low | $ | |||
| Day High | $7.95 | P/E | N/A | |||
| Day Low | $6.72 | EPS | $ | |||
| Volume | 461,353 | |||||

